MedPath

Doxycycline

Generic Name
Doxycycline
Brand Names
Acticlate, Adoxa, Apprilon, Atridox, Doryx, Doxy, Doxycin, Lymepak, Mondoxyne, Monodox, Morgidox, Okebo, Oracea, Periostat, Targadox, Vibramycin
Drug Type
Small Molecule
Chemical Formula
C22H24N2O8
CAS Number
564-25-0
Unique Ingredient Identifier
334895S862

Overview

Doxycycline is a broad-spectrum antibiotic synthetically derived from oxytetracycline. It is a second-generation tetracycline that was first discovered in 1967. Second-generation tetracyclines exhibit lesser toxicity than first-generation tetracyclines. Doxycycline is used to treat a wide variety of gram-positive and gram-negative bacterial infections. It is also used to treat acne and malaria.

Background

Doxycycline is a broad-spectrum antibiotic synthetically derived from oxytetracycline. It is a second-generation tetracycline that was first discovered in 1967. Second-generation tetracyclines exhibit lesser toxicity than first-generation tetracyclines. Doxycycline is used to treat a wide variety of gram-positive and gram-negative bacterial infections. It is also used to treat acne and malaria.

Indication

Doxycycline is indicated for the treatment of various infections by gram-positive and gram-negative bacteria, aerobes and anaerobes, as well other types of bacteria, including: It is also used to treat infections caused by the following gram-negative microorganisms:

Associated Conditions

  • Acinetobacter Infections
  • Anthrax
  • Bacterial Infection caused by Enterobacter aerogenes
  • Bartonellosis
  • Brucellosis
  • Campylobacter Infection
  • Chancroid
  • Chlamydia Trachomatis Infection
  • Early Lyme Disease
  • Granuloma Inguinale
  • Infection Due to Escherichia Coli
  • Inhalational Anthrax
  • Klebsiella Infections
  • Lymphogranuloma Venereum
  • Malaria caused by Plasmodium falciparum
  • Nongonococcal urethritis
  • Plague caused by Yersinia pestis
  • Psittacosis
  • Rectal infection caused by Chlamydia Trachomatis
  • Relapsing fever caused by Borrelia recurrentis
  • Respiratory Tract Infection Bacterial
  • Rickettsial infectious disorders
  • Severe Acne
  • Sexually Transmitted Infections (STIs)
  • Shigella Infection
  • Trachoma inclusion conjunctivitis
  • Tularemia
  • Vibrio Cholerae Infection
  • Acute Intestinal amebiasis
  • Susceptible Bacterial Infections
  • Uncomplicated endocervical infection
  • Uncomplicated urethral infection

FDA Approved Products

Doxycycline Hyclate
Manufacturer:Alembic Pharmaceuticals Limited
Route:ORAL
Strength:200 mg in 1 1
Approved: 2023/04/10
NDC:46708-484
Doxycycline Hyclate
Manufacturer:Golden State Medical Supply, Inc.
Route:ORAL
Strength:100 mg in 1 1
Approved: 2023/10/31
NDC:51407-298
doxycycline hyclate
Manufacturer:Alembic Pharmaceuticals Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2021/10/12
NDC:62332-362
Doxycycline
Manufacturer:Proficient Rx LP
Route:ORAL
Strength:100 mg in 1 1
Approved: 2023/10/01
NDC:82804-028
Doxycycline Hyclate
Manufacturer:Larken Laboratories, Inc.
Route:ORAL
Strength:20 mg in 1 1
Approved: 2023/12/15
NDC:68047-714

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath